Logo image of VAPE

CEA INDUSTRIES INC (VAPE) Stock Fundamental Analysis

NASDAQ:VAPE - Nasdaq - US86887P3091 - Common Stock - Currency: USD

17.77  +0.34 (+1.95%)

After market: 18.29 +0.52 (+2.93%)

Fundamental Rating

2

Taking everything into account, VAPE scores 2 out of 10 in our fundamental rating. VAPE was compared to 41 industry peers in the Building Products industry. While VAPE has a great health rating, there are worries on its profitability. VAPE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VAPE had negative earnings in the past year.
In the past year VAPE has reported a negative cash flow from operations.
In the past 5 years VAPE always reported negative net income.
In the past 5 years VAPE reported 4 times negative operating cash flow.
VAPE Yearly Net Income VS EBIT VS OCF VS FCFVAPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -34.95%, VAPE is doing worse than 95.12% of the companies in the same industry.
Looking at the Return On Equity, with a value of -40.18%, VAPE is doing worse than 85.37% of the companies in the same industry.
Industry RankSector Rank
ROA -34.95%
ROE -40.18%
ROIC N/A
ROA(3y)-26.63%
ROA(5y)-37.27%
ROE(3y)-32.67%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VAPE Yearly ROA, ROE, ROICVAPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VAPE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VAPE Yearly Profit, Operating, Gross MarginsVAPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

VAPE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VAPE has been increased compared to 1 year ago.
Compared to 5 years ago, VAPE has less shares outstanding
There is no outstanding debt for VAPE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VAPE Yearly Shares OutstandingVAPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
VAPE Yearly Total Debt VS Total AssetsVAPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of 1.36, we must say that VAPE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.36, VAPE is not doing good in the industry: 85.37% of the companies in the same industry are doing better.
VAPE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACCN/A
WACC10.31%
VAPE Yearly LT Debt VS Equity VS FCFVAPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

VAPE has a Current Ratio of 8.16. This indicates that VAPE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.16, VAPE belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
VAPE has a Quick Ratio of 8.14. This indicates that VAPE is financially healthy and has no problem in meeting its short term obligations.
VAPE's Quick ratio of 8.14 is amongst the best of the industry. VAPE outperforms 97.56% of its industry peers.
Industry RankSector Rank
Current Ratio 8.16
Quick Ratio 8.14
VAPE Yearly Current Assets VS Current LiabilitesVAPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for VAPE have decreased by -3.18% in the last year.
Looking at the last year, VAPE shows a very strong growth in Revenue. The Revenue has grown by 33.48%.
VAPE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -28.71% yearly.
EPS 1Y (TTM)-3.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.58%
Revenue 1Y (TTM)33.48%
Revenue growth 3Y-40.98%
Revenue growth 5Y-28.71%
Sales Q2Q%204.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VAPE Yearly Revenue VS EstimatesVAPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VAPE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VAPE Price Earnings VS Forward Price EarningsVAPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VAPE Per share dataVAPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VAPE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEA INDUSTRIES INC

NASDAQ:VAPE (8/5/2025, 8:00:02 PM)

After market: 18.29 +0.52 (+2.93%)

17.77

+0.34 (+1.95%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners6.4%
Inst Owner ChangeN/A
Ins Owners6.25%
Ins Owner Change0%
Market Cap14.93M
AnalystsN/A
Price TargetN/A
Short Float %0.17%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.55
P/FCF N/A
P/OCF N/A
P/B 1.82
P/tB 1.82
EV/EBITDA N/A
EPS(TTM)-4.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.44
FCFYN/A
OCF(TTM)-3.44
OCFYN/A
SpS3.91
BVpS9.77
TBVpS9.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.95%
ROE -40.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.63%
ROA(5y)-37.27%
ROE(3y)-32.67%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.16
Quick Ratio 8.14
Altman-Z 1.36
F-Score4
WACC10.31%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.48%
Revenue growth 3Y-40.98%
Revenue growth 5Y-28.71%
Sales Q2Q%204.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.36%
OCF growth 3YN/A
OCF growth 5YN/A